secwatch.observer — SEC 8-K summary
======================================

Issuer:     Design Therapeutics, Inc. (DSGN)
CIK:        0001807120
Form:       8-K
Filed at:   2025-09-10T23:59:59+00:00
Accession:  0001807120-25-000004
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Design Therapeutics director resigns; Justin Gover appointed to board
---------------------------------------------------------------------

- Arsani William, M.D. resigned from board effective Sept 9, 2025, not due to any disagreement.
- Board appointed Justin Gover as Class III director with term ending at 2027 annual meeting.
- Gover also named chair of Compensation Committee.
- Gover receives annual cash retainers of $40,000 for board service and $12,000 as committee chair.
- Gover granted initial option for 30,000 shares vesting over 3 years and prorated grant of 15,833 shares vesting over 1 year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1807120/000180712025000004/0001807120-25-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1807120/000180712025000004/dsgn-20250909.htm
  HTML page:      https://secwatch.observer/filing/0001807120-25-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer